No Data
No Data
Craig-Hallum Releases a Buy Rating on ScPharmaceuticals (SCPH)
Express News | ScPharmaceuticals Inc - FDA Has Assigned a Prescription Drug User Fee Act (Pdufa) Target Action Date of March 6, 2025
Express News | ScPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (Snda) Seeking to Expand Furoscix Indication to Include Chronic Kidney Disease
When Will ScPharmaceuticals Inc. (NASDAQ:SCPH) Breakeven?
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
These 2 'Strong Buy' Penny Stocks Are Poised for a Massive Rally, Say Analysts
No Data